50242-0933 Tecentriq Hybreza

Product NDC:

50242-0933

Brand Name:

Tecentriq Hybreza

Generic Name:

Atezolizumab and hyaluronidase-tqjs

Dosage Form Name:

INJECTION

Administration Route:

Subcutaneous

Substances:

Name: ATEZOLIZUMAB

Strength: 1875.0

Unit: mg/15mL

Name: HYALURONIDASE (HUMAN RECOMBINANT)

Strength: 30000.0

Unit: U/15mL

Packages:

Code: 50242-0933-01

Description: 1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01) / 15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Sept. 12, 2024

Discontinued:

Code: 50242-0933-86

Description: 1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86) / 15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Sept. 12, 2024

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-L1

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox